PRAX
Praxis Precision Medicines Inc

1,666
Mkt Cap
$6.68B
Volume
403,030.00
52W High
$278.44
52W Low
$26.70
PE Ratio
-20.83
PRAX Fundamentals
Price
$268.80
Prev Close
$267.28
Open
$263.98
50D MA
$169.10
Beta
0.55
Avg. Volume
965,649.11
EPS (Annual)
-$10.21
P/B
16.56
Rev/Employee
$73,732.76
Loading...
Loading...
News
all
press releases
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Reduces Stock Position in Praxis Precision Medicines, Inc. $PRAX
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 18.3% in the 2nd quarter, according to the...
MarketBeat·24h ago
News Placeholder
More News
News Placeholder
HighVista Strategies LLC Buys 28,002 Shares of Praxis Precision Medicines, Inc. $PRAX
HighVista Strategies LLC increased its stake in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 71.3% during the 2nd quarter, according to the company in its most recent...
MarketBeat·2d ago
News Placeholder
Velan Capital Investment Management LP Sells 35,666 Shares of Praxis Precision Medicines, Inc. $PRAX
Velan Capital Investment Management LP trimmed its holdings in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 19.3% during the second quarter, according to the company in...
MarketBeat·3d ago
News Placeholder
Stempoint Capital LP Takes $1.36 Million Position in Praxis Precision Medicines, Inc. $PRAX
Stempoint Capital LP bought a new stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought...
MarketBeat·3d ago
News Placeholder
Maven Securities LTD Buys Shares of 5,000 Praxis Precision Medicines, Inc. $PRAX
Maven Securities LTD purchased a new stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) during the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·3d ago
News Placeholder
Vivo Capital LLC Takes Position in Praxis Precision Medicines, Inc. $PRAX
Vivo Capital LLC acquired a new position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·4d ago
News Placeholder
Praxis Precision Medicines, Inc. $PRAX Stock Holdings Boosted by B Group Inc.
B Group Inc. grew its position in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 84.2% during the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·4d ago
News Placeholder
Praxis Precision Medicines (NASDAQ:PRAX) Price Target Raised to $353.00
TD Cowen upped their price target on shares of Praxis Precision Medicines from $251.00 to $353.00 and gave the company a "buy" rating in a report on Monday...
MarketBeat·5d ago
News Placeholder
Praxis Precision Medicines (NASDAQ:PRAX) Given New $500.00 Price Target at Truist Financial
Truist Financial lifted their target price on shares of Praxis Precision Medicines from $360.00 to $500.00 and gave the stock a "buy" rating in a research note on Monday...
MarketBeat·5d ago
News Placeholder
Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Up 9.2% Following Analyst Upgrade
Praxis Precision Medicines (NASDAQ:PRAX) Trading 9.2% Higher Following Analyst Upgrade...
MarketBeat·5d ago

Latest PRAX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.